These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20130984)

  • 1. Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer.
    Gierach GL; Loud JT; Chow CK; Prindiville SA; Eng-Wong J; Soballe PW; Giambartolomei C; Mai PL; Galbo CE; Nichols K; Calzone KA; Vachon C; Gail MH; Greene MH
    Breast Cancer Res Treat; 2010 Aug; 123(1):245-55. PubMed ID: 20130984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammographic density and breast cancer in women from high risk families.
    Ramón Y Cajal T; Chirivella I; Miranda J; Teule A; Izquierdo Á; Balmaña J; Sánchez-Heras AB; Llort G; Fisas D; Lope V; Hernández-Agudo E; Juan-Fita MJ; Tena I; Robles L; Guillén-Ponce C; Pérez-Segura P; Luque-Molina MS; Hernando-Polo S; Salinas M; Brunet J; Salas-Trejo MD; Barnadas A; Pollán M
    Breast Cancer Res; 2015 Jul; 17(1):93. PubMed ID: 26163143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers.
    Mitchell G; Antoniou AC; Warren R; Peock S; Brown J; Davies R; Mattison J; Cook M; Warsi I; Evans DG; Eccles D; Douglas F; Paterson J; Hodgson S; Izatt L; Cole T; Burgess L; Eeles R; Easton DF
    Cancer Res; 2006 Feb; 66(3):1866-72. PubMed ID: 16452249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between computer-extracted mammographic texture pattern features and BRCA1/2 mutation status: a cross-sectional study.
    Gierach GL; Li H; Loud JT; Greene MH; Chow CK; Lan L; Prindiville SA; Eng-Wong J; Soballe PW; Giambartolomei C; Mai PL; Galbo CE; Nichols K; Calzone KA; Olopade OI; Gail MH; Giger ML
    Breast Cancer Res; 2014; 16(4):424. PubMed ID: 25159706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computerized analysis of digitized mammograms of BRCA1 and BRCA2 gene mutation carriers.
    Huo Z; Giger ML; Olopade OI; Wolverton DE; Weber BL; Metz CE; Zhong W; Cummings SA
    Radiology; 2002 Nov; 225(2):519-26. PubMed ID: 12409590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of mammographic density among women with a strong family history of breast cancer.
    Moran O; Eisen A; Demsky R; Blackmore K; Knight JA; Panchal S; Ginsburg O; Zbuk K; Yaffe M; Metcalfe KA; Narod SA; Kotsopoulos J
    BMC Cancer; 2019 Jun; 19(1):631. PubMed ID: 31242899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of BRCA Mutation Types, Imaging Features, and Pathologic Findings in Patients With Breast Cancer With BRCA1 and BRCA2 Mutations.
    Ha SM; Chae EY; Cha JH; Kim HH; Shin HJ; Choi WJ
    AJR Am J Roentgenol; 2017 Oct; 209(4):920-928. PubMed ID: 28796549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography.
    Tilanus-Linthorst M; Verhoog L; Obdeijn IM; Bartels K; Menke-Pluymers M; Eggermont A; Klijn J; Meijers-Heijboer H; van der Kwast T; Brekelmans C
    Int J Cancer; 2002 Nov; 102(1):91-5. PubMed ID: 12353239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive factors in hereditary breast cancer.
    Jernström HC; Johannsson OT; Loman N; Borg A; Olsson H
    Breast Cancer Res Treat; 1999 Dec; 58(3):295-301. PubMed ID: 10718491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: the UK MARIBS study.
    Thompson DJ; Leach MO; Kwan-Lim G; Gayther SA; Ramus SJ; Warsi I; Lennard F; Khazen M; Bryant E; Reed S; Boggis CR; Evans DG; Eeles RA; Easton DF; Warren RM;
    Breast Cancer Res; 2009; 11(6):R80. PubMed ID: 19903338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers.
    Cullinane CA; Lubinski J; Neuhausen SL; Ghadirian P; Lynch HT; Isaacs C; Weber B; Moller P; Offit K; Kim-Sing C; Friedman E; Randall S; Pasini B; Ainsworth P; Gershoni-Baruch R; Foulkes WD; Klijn J; Tung N; Rennert G; Olopade O; Couch F; Wagner T; Olsson H; Sun P; Weitzel JN; Narod SA
    Int J Cancer; 2005 Dec; 117(6):988-91. PubMed ID: 15986445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical impact of MRI screening for BRCA mutation carriers: the first report in Japan.
    Murakami W; Tozaki M; Nakamura S; Ide Y; Inuzuka M; Hirota Y; Murakami K; Takahama N; Ohgiya Y; Gokan T
    Breast Cancer; 2019 Sep; 26(5):552-561. PubMed ID: 30820924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.
    Plevritis SK; Kurian AW; Sigal BM; Daniel BL; Ikeda DM; Stockdale FE; Garber AM
    JAMA; 2006 May; 295(20):2374-84. PubMed ID: 16720823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic chest X-rays and breast cancer risk before age 50 years for BRCA1 and BRCA2 mutation carriers.
    John EM; McGuire V; Thomas D; Haile R; Ozcelik H; Milne RL; Felberg A; West DW; Miron A; Knight JA; Terry MB; Daly M; Buys SS; Andrulis IL; Hopper JL; Southey MC; Giles GG; Apicella C; Thorne H; ; Whittemore AS
    Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1547-56. PubMed ID: 23853209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers.
    Berrington de Gonzalez A; Berg CD; Visvanathan K; Robson M
    J Natl Cancer Inst; 2009 Feb; 101(3):205-9. PubMed ID: 19176458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study.
    Giannakeas V; Lubinski J; Gronwald J; Moller P; Armel S; Lynch HT; Foulkes WD; Kim-Sing C; Singer C; Neuhausen SL; Friedman E; Tung N; Senter L; Sun P; Narod SA
    Breast Cancer Res Treat; 2014 Aug; 147(1):113-8. PubMed ID: 25082516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.
    Warner E; Plewes DB; Hill KA; Causer PA; Zubovits JT; Jong RA; Cutrara MR; DeBoer G; Yaffe MJ; Messner SJ; Meschino WS; Piron CA; Narod SA
    JAMA; 2004 Sep; 292(11):1317-25. PubMed ID: 15367553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
    Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
    Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is mammographic breast density a breast cancer risk factor in women with BRCA mutations?
    Passaperuma K; Warner E; Hill KA; Gunasekara A; Yaffe MJ
    J Clin Oncol; 2010 Aug; 28(23):3779-83. PubMed ID: 20625126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
    Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
    Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.